Article
Suppression of Mouse AApoAII Amyloidosis Progression by Daily Supplementation with…
Oxidative Medicine and Cellular Longevity · 2019 · Jian Dai, author Xin Ding, author Hiroki Miyahara, author Zhe Xu, author Xiaoran Cui, author Yuichi Igarashi, author Jinko Sawashita, author Masayuki Mori, author Keiichi Higuchi, author Federica Rizzi, Guest Editor
Key facts
| Title | Suppression of Mouse AApoAII Amyloidosis Progression by Daily Supplementation with Oxidative Stress Inhibitors |
|---|---|
| First author | Jian Dai, author Xin Ding, author Hiroki Miyahara, author Zhe Xu, author Xiaoran Cui, author Yuichi Igarashi, author Jinko Sawashita, author Masayuki Mori, author Keiichi Higuchi, author Federica Rizzi, Guest Editor |
| Journal | Oxidative Medicine and Cellular Longevity |
| Published | Mar 12, 2019 |
| DOI | 10.1155/2019/1263274 |
| Devices mentioned | K800552, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840, K920529, K920967, K923274 and 11 more |
| Product codes mentioned | DEH, EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, KKX |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1